27 studies found for:    "Diabetes Insipidus, Neurogenic" [DISEASE]
Show Display Options
Rank Status Study
1 Recruiting Metformin and Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: Metformin
2 Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Condition: Nephrogenic Diabetes Insipidus
Interventions: Drug: sildenafil;   Drug: calcitonin;   Drug: hydrochlorothiazide/amiloride;   Drug: indomethacin;   Drug: Placebo for sildenafil;   Drug: placebo for calcitonin
3 Completed Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Condition: Diabetes Insipidus
4 Recruiting Use of Copeptin in Diabetes Insipidus
Conditions: Diabetes Insipidus (Central and Nephrogen);   Primary Polydipsia
Interventions: Other: Water deprivation test;   Other: Water deprivationtest;   Other: Hypertonic saline infusion
5 Completed Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Conditions: Diabetes Insipidus;   Diabetes Insipidus, Neurohypophyseal
Interventions: Drug: chlorpropamide;   Drug: desmopressin
6 Completed Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Condition: Diabetes Insipidus, Nephrogenic
Intervention: Drug: chlorothiazide
7 Unknown  Study of Novel Types of Familial Diabetes Insipidus
Condition: Diabetes Insipidus
Intervention: Drug: desmopressin
8 Completed A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).
Condition: Central Diabetes Insipidus
Interventions: Drug: Desmopressin Oral Melt;   Drug: Desmopressin intranasal
9 Completed Vasopressin Deficiency in Hemorrhagic Shock
Condition: Body Response to Trauma
Intervention: Other: Phlebotomy
10 Completed Effect of Statin Treatment on Urinary AQP2 (uAQP2/01)
Conditions: Hypercholesterolemia;   Diabetes Insipidus
11 Recruiting Tracking Neurodegeneration in Early Wolfram Syndrome
Conditions: Type 1 Diabetes;   Diabetes Insipidus;   Diabetes Mellitus;   Wolfram Syndrome
12 Active, not recruiting Peer Support to Enhance Diabetes Shared Medical Appointments: Examining Comparative Effectiveness in VA Health Systems
Condition: Diabetes Insipidus
13 Completed V2 Receptor Effects on Fluid Regulation and Performance
Condition: Determine if Sweat [Na+] is Regulated by the V2R
Intervention: Drug: V2R (Vasopressin 2 receptor)
14 Completed A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Condition: Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Intervention: Drug: tolvaptan
15 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
16 Terminated Oxytocin and Arginine Vasopressin in Pain Relief
Condition: Placebo Analgesia
17 Completed
Has Results
1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy
Condition: Kidney Failure
Interventions: Drug: DDAVP;   Drug: saline solution
18 Unknown  Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Conditions: Chronic Hepatitis C;   Chronic Hepatitis B;   Biopsy;   Hemodialysis
Intervention: Procedure: Percutaneous liver biopsy
19 Completed The Effects of Estradiol and Progesterone on Arginine Vasopressin Regulation and Serum Sodium Concentration
Condition: Exercise Induced Hyponatremia
Interventions: Dietary Supplement: Gatorade Endurance Formula;   Other: ganirelix acetate
20 Completed Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Conditions: Inappropriate ADH Syndrome;   Hyponatremia
Intervention: Drug: SR121463B

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years